AGER and cancer: The interaction between S100 proteins and their principal receptor, RAGE (Receptor for Advanced Glycation End-products), represents a critical molecular axis in both physiological and pathological signaling, especially in the context of inflammation, cancer, and neurodegeneration [97,98,99].